Qualigen Therapeutics 股东以多数票通过所有提案;公司将在 11 月 20 日的纳斯达克仪式后更名为 Aixcrypto Holdings, Inc.(纳斯达克:Aixc),并宣布转型至 AI × Web3 战略。
Qualigen Therapeutics 股东以多数票通过所有提案;公司将在 11 月 20 日的纳斯达克仪式后更名为 Aixcrypto Holdings, Inc.(纳斯达克:Aixc),并宣布转型至 AI × Web3 战略。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.